The landscape of hormone replacement therapy (HRT) and other medications is constantly evolving. Recently, the black box warning on HRT was removed, highlighting the importance of context when evaluating drug safety. From post-finasteride syndrome to FDA approval nuances, and the safety of compounding pharmacies, this guide explains what patients and providers need to know to make informed choices about hormonal and non-hormonal therapies. What You’ll Learn in This Video 1️⃣ HRT Black Box Up...